A new device shown at CES 2026 could let people with food allergies test their meals at the table. The Allergen Alert mini lab is a portable, battery-operated gadget that provides near-instant results for gluten and common allergens.
The legendary fund that seeded D.E. Shaw is trying to reinvent itself again. After a turbulent 18 months, new CEO Ravi Singh is pushing a diversified, talent-friendly strategy. But can it compete with giants like Citadel and Millennium?
A new hosting service called pico.sh is challenging the likes of GitHub Pages by making everything work over a simple SSH connection. You can deploy a static site, blog, or share code snippets with single commands like rsync and scp, all for free.
Mumbai-based Knight Fintech, which builds core banking infrastructure, has secured $23.6 million in a funding round led by Accel. The news prompted a sharp debate on social media about AI’s potential to disrupt the traditional economic relationship between capital and wages.
Asus has told telecom channels it will not introduce new smartphone models in 2026. The company insists it will maintain operations and support for existing devices, but the pause highlights the brutal challenges for PC brands in the mobile market.
The annual tech forecast is out, and it’s not about the latest AI chatbot. It’s about physical, tangible engineering solving massive problems. From compressing CO2 in giant domes to using radio waves inside servers, the ideas are brilliantly weird.
While AI giants grabbed headlines, the biggest stock gains came from a different set of companies. Western Digital, Micron, Seagate, Robinhood, and Warner Bros. Discovery soared, with the first four more than tripling. Here’s what drove their incredible runs and what might come next.
In a major shift, CD Projekt has sold the GOG.com storefront to its original co-founder, Michal Kicinski. The deal, worth roughly £19 million, aims to let CD Projekt focus solely on game development while keeping GOG’s DRM-free philosophy alive.
Insilico Medicine, an AI drug discovery startup, saw its shares surge 25% on its first day of trading in Hong Kong. The $293 million IPO caps a year of intense investor interest in Chinese biotech and AI. The company plans to scale its drug discovery efforts and develop new AI models with the fresh
A new lifetime subscription bundles unlimited access to over 25 major AI models into a single dashboard for a one-time $79 payment. The promise is to end subscription hopping and credit-wasting by letting you compare responses side-by-side. But does aggregating access to models you don’t own actuall
